Clinical Trial Update: Oral Clofarabine in Chronic Lymphocytic Leukemia (CLL) [Phase 1]

View source ↗

Summary

A Phase 1 study of oral clofarabine for chronic lymphocytic leukemia has been withdrawn (sponsored by MD Anderson Cancer Center).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia

Drugs mentioned

• Clofarabine (Clolar) (clofarabine)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Leukemia, Chronic Lymphocytic Leukemia | Phase 1 | Status: WITHDRAWN